“终止结核病”面临的挑战与应对策略

doi:10.3969/j.issn.1000-6621.2020.04.002

中国防痨杂志 ›› 2020, Vol. 42 ›› Issue (4): 308-310.doi: 10.3969/j.issn.1000-6621.2020.04.002

“终止结核病”面临的挑战与应对策略

刘健雄(),钟球

510095 广州市胸科医院(刘健雄);广东省结核病控制中心(钟球)

收稿日期:2020-03-03 出版日期:2020-04-10 发布日期:2020-04-07
通信作者: 刘健雄 E-mail:Ljxer64@qq.com
基金资助:
广州市卫生健康科技重大项目(2020A031003)

Received:2020-03-03 Online:2020-04-10 Published:2020-04-07

摘要/Abstract

刘健雄,钟球. “终止结核病”面临的挑战与应对策略[J]. 中国防痨杂志, 2020, 42(4): 308-310. doi: 10.3969/j.issn.1000-6621.2020.04.002

参考文献 25

[1]	World Health Organization. The End TB Strategy. Geneva: World Health Organization, 2014.
[2]	World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
[3]	Floyd K, Glaziou P, Zumla A , et al. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. Lancet Respir Med, 2018,6(4):299-314.
[4]	中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版). 北京: 中国协和医科大学出版社, 2009.
[5]	Khan MS, Wu S, Wang X , et al. Optimising routine surveillance systems for informing tuberculosis control policies in China. Health Policy Plan, 2017,2 Suppl 2: i12-i14.
[6]	Theron G, Jenkins HE, Cobelens F , et al. Data for action: collection and use of local data to end tuberculosis. Lancet, 2015,386(10010):2324-2333.
[7]	Walzl G, McNerney R, du Plessis N , et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis, 2018,18(7):e199-210.
[8]	Meehan CJ, Goig GA, Kohl TA , et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol, 2019,17(9):533-545.
[9]	Bomanji JB, Gupta N, Gulati P , et al. Imaging in tuberculosis. Cold Spring Harb Perspect Med, 2015, 5(6). pii: a017814.
[10]	Garg M, Prabhakar N, Gulati A , et al. Spectrum of imaging findings in pulmonary infections. Part 2:Fungal,mycobacterial,and parasitic. Pol J Radiol, 2019,84:e214-223.
[11]	Saunders MJ, Tovar MA, Collier D , et al. Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study. Lancet Infect Dis, 2019,19(5):519-528.
[12]	Chen JO, Qiu YB, Rueda ZV , et al. Role of community-based active case finding in screening tuberculosis in Yunnan province of China. Infect Dis Poverty, 2019,8(1):92.
[13]	Horsburgh CR Jr, Barry CE 3rd, Lange C. Treatment of tuberculosis. N Engl J Med, 2015,373(22):2149-2160.
[14]	Wilkinson RJ, Rohlwink U, Misra UK , et al. Tuberculous meningitis. Nat Rev Neurol, 2017,13(10):581-598.
[15]	Mer M, Zumla A, Dünser MW , et al. Limiting consumption in tuberculosis: current concepts in anti-tuberculosis treatment in the critically ill patient. Intensive Care Med, 2018,44(12):2229-2231.
[16]	Dheda K, Gumbo T, Maartens G , et al. The Lancet Respiratory Medicine Commission: 2019 update:epidemiology,pathogenesis,transmission,diagnosis,and management of multidrug-resistant and incurable tuberculosis. Lancet Respir Med, 2019,7(9):820-826.
[17]	Bell LCK, Noursadeghi M . Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol, 2018,16(2):80-90.
[18]	Tiberi S, Plessis N, Walzl G , et al. Tuberculosis: progress and advances in development of new drugs,treatment regimens,and host-directed therapies. Lancet Infect Dis, 2018,18(7):e183-198.
[19]	Shah I, Poojari V, Meshram H . Multi-drug resistant and extensively-drug resistant tuberculosis. Indian J Pediatr, 2020.[Epub ahead of print].
[20]	Alipanah N, Jarlsberg L, Miller C , et al. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med, 2018,15(7):e1002595.
[21]	Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev, 2015,(5):CD003343.
[22]	Ngwatu BK, Nsengiyumva NP, Oxlade O , et al. The impact of digital health technologies on tuberculosis treatment:a systema-tic review. Eur Respir J, 2018, 51(1). pii: 1701596.
[23]	李智, 周惠, 陈晓军 , 等. 基于数字技术的结核病患者管理方法研究进展. 中国防痨杂志, 2019,41(9):1015-1020.
[24]	Agins BD, Ikeda DJ, Reid MJA , et al. Improving the cascade of global tuberculosis care: moving from the “what” to the “how” of quality improvement. Lancet Infect Dis, 2019,19(12):e437-443.
[25]	Reid MJA, Arinaminpathy N, Bloom A , et al. Building a tuberculosis-free world: The Lancet Commission on Tuberculosis. Lancet, 2019,393(10178):1331-1384.

“终止结核病”面临的挑战与应对策略

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 0

编辑推荐

Metrics

本文评价

友情链接